Cargando…
Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?—The Metabolite Hypothesis
Despite decades of research to elucidate the cancer preventive mechanisms of aspirin and flavonoids, a consensus has not been reached on their specific modes of action. This inability to accurately pinpoint the mechanism involved is due to the failure to differentiate the primary targets from its as...
Autores principales: | Sankaranarayanan, Ranjini, Kumar, D. Ramesh, Patel, Janki, Bhat, G. Jayarama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249170/ https://www.ncbi.nlm.nih.gov/pubmed/32397626 http://dx.doi.org/10.3390/molecules25092243 |
Ejemplares similares
-
Aspirin metabolites 2,3-DHBA and 2,5-DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2020) -
Mechanisms of Colorectal Cancer Prevention by Aspirin—A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2020) -
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
por: Dachineni, Rakesh, et al.
Publicado: (2017) -
The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2019) -
Screening of Human Gut Bacterial Culture Collection Identifies Species That Biotransform Quercetin into Metabolites with Anticancer Properties
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2021)